Schwartz EL - Search Results

1

Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells.

Schwartz EL, Hoffman M, O'Connor CJ, Wadler S. Schwartz EL, et al. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1232-9. doi: 10.1016/0006-291x(92)91863-l. Biochem Biophys Res Commun. 1992. PMID: 1540167

2

Principles in the biomodulation of cytotoxic drugs by interferons.

Wadler S, Schwartz EL. Wadler S, et al. Among authors: schwartz el. Semin Oncol. 1992 Apr;19(2 Suppl 3):45-8. Semin Oncol. 1992. PMID: 1373005 Review.

3

Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.

Wadler S, Schwartz EL. Wadler S, et al. Among authors: schwartz el. Cancer Res. 1990 Jun 15;50(12):3473-86. Cancer Res. 1990. PMID: 1692761 Review.

4

Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.

Wadler S, Wersto R, Weinberg V, Thompson D, Schwartz EL. Wadler S, et al. Among authors: schwartz el. Cancer Res. 1990 Sep 15;50(18):5735-9. Cancer Res. 1990. PMID: 1697499

5

Inhibition of c-myc expression in human promyelocytic leukemia and colon adenocarcinoma cells by 6-thioguanine.

Schwartz EL, Chamberlin H, Brechbühl AB. Schwartz EL, et al. Biochem Pharmacol. 1990 Dec 1;40(11):2449-55. doi: 10.1016/0006-2952(90)90085-y. Biochem Pharmacol. 1990. PMID: 1702632

6

Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.

Sparano JA, Schwartz EL, Salva KM, Pizzillo MF, Wadler S, Wiernik PH. Sparano JA, et al. Among authors: schwartz el. Am J Clin Oncol. 1990 Oct;13(5):374-8. doi: 10.1097/00000421-199010000-00002. Am J Clin Oncol. 1990. PMID: 2220657

7

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.

Wadler S, Schwartz EL, Goldman M, Lyver A, Rader M, Zimmerman M, Itri L, Weinberg V, Wiernik PH. Wadler S, et al. Among authors: schwartz el. J Clin Oncol. 1989 Dec;7(12):1769-75. doi: 10.1200/JCO.1989.7.12.1769. J Clin Oncol. 1989. PMID: 2585018

8

Biologic agents as biochemical modulators: pharmacologic basis for the interaction of cytotoxic chemotherapeutic drugs and interferon.

Wadler S, Schwartz EL. Wadler S, et al. Among authors: schwartz el. Cancer Chemother Pharmacol. 1994;35(1):21-30. doi: 10.1007/BF00686280. Cancer Chemother Pharmacol. 1994. PMID: 7527304 Review.

9

Chemotherapy for colorectal carcinoma: observations regarding recent clinical trials using biochemical modulation.

Wadler S, Schwartz EL. Wadler S, et al. Among authors: schwartz el. J Clin Oncol. 1995 Oct;13(10):2676-7. doi: 10.1200/JCO.1995.13.10.2676. J Clin Oncol. 1995. PMID: 7595721 No abstract available.

10

5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.

Schwartz EL, Baptiste N, Megati S, Wadler S, Otter BA. Schwartz EL, et al. Cancer Res. 1995 Aug 15;55(16):3543-50. Cancer Res. 1995. PMID: 7627962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters